Forum Financial Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,252
Closed -$1.7M 398
2025
Q4
$1.7M Sell
9,252
-17
-0.2% -$2.98K 0.02% 157
2025
Q3
$1.42M Buy
9,269
+191
+2% +$28.9K 0.02% 183
2025
Q2
$1.27M Buy
9,078
+299
+3% +$41.9K 0.02% 181
2025
Q1
$1.29M Buy
+8,779
New +$1.27M 0.02% 171
2024
Q4
Sell
-5,687
Closed -$886K 925
2024
Q3
$886K Buy
5,687
+1
+0% +$161 0.01% 204
2024
Q2
$887K Hold
5,686
0.02% 196
2024
Q1
$770K Buy
5,686
+189
+3% +$25K 0.01% 232
2023
Q4
$740K Sell
5,497
-16
-0.3% -$2.08K 0.01% 205
2023
Q3
$747K Buy
5,513
+17
+0.3% +$2.32K 0.02% 198
2023
Q2
$787K Sell
5,496
-9
-0.2% -$1.32K 0.02% 191
2023
Q1
$764K Buy
5,505
+105
+2% +$14.1K 0.02% 180
2022
Q4
$732K Buy
5,400
+4
+0.1% +$502 0.02% 187
2022
Q3
$592K Sell
5,396
-1
-0% -$127 0.03% 195
2022
Q2
$713K Buy
5,397
+1
+0% +$131 0.04% 166
2022
Q1
$715K Sell
5,396
-5
-0.1% -$600 0.03% 177
2021
Q4
$629K Buy
+5,401
New +$636K 0.03% 200

Other funds holding AZN

Forum Financial Management's AZN Position: Q1 2026 in Review

Forum Financial Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 9,252 shares — an estimated $1.7M sold.

Forum Financial Management first reported a position in AZN in Q4 2021 and held it in 16 quarters. The position peaked at $1.7M in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Forum Financial Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Forum Financial Management sold 9,252 AstraZeneca shares in Q1 2026, an estimated $1.7M.
  • Forum Financial Management first reported a position in AstraZeneca in Q4 2021 and held it in 16 quarters.
  • Forum Financial Management's AstraZeneca position peaked at $1.7M in Q4 2025.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Forum Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.